UCB SA - Company Profile
Powered by
All the data and insights you need on UCB SA in one report.
$295
- Save hours of research time and resources with
our up-to-date UCB SA Strategy Report
- Understand UCB SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View up-to-date information on UCB SA patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
UA126295C2 | Grant | ANTI-ALPHA-SYNUCLEIN ANTIBODIES | A61K2039/505; A61P25/16; C07K16/18; C07K2317/24; C07K2317/33; C07K2317/34; C07K2317/51; C07K2317/515; C07K2317/55; C07K2317/56; C07K2317/565; C07K2317/567; C07K2317/76; C07K2317/92; C07K2317/94; G01N2800/2835; G01N33/6896 | September 14, 2022 |
CN115052900A | Application | 抗KLK5抗体 | A61P17/00; A61P35/00; C07K16/40; C07K2317/24; C07K2317/34; C07K2317/76; C07K2317/92; C07K2317/94 | September 13, 2022 |
JP2022539538A | Application | IL-17調節剤としての縮合イミダゾール誘導体 | A61K31/4245; A61K31/4353; A61K31/4439; A61K31/497; A61K31/501; A61K31/519; A61K45/06; A61P29/00; A61P37/00; C07D403/14; C07D405/14; C07D413/14; C07D417/14; C07D487/04; C07D498/04 | September 12, 2022 |
CN115038722A | Application | 针对KLK5的抗体 | A61P17/00; A61P35/00; C07K16/40; C07K2317/24; C07K2317/34; C07K2317/76; C07K2317/92; C07K2317/94 | September 09, 2022 |
US20220280887A1 | Application | METHODS FOR PURIFYING ANTIBODIES | B01D15/3809; C07K1/18; C07K1/22; C07K16/065; C07K16/12 | September 08, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer